Screening for hemochromatosis in primary care settings

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 962-970

  McDonnell, Sharon M ^a   Phatak, Pradyumna D ^b   Felitti, Vincent ^c   Hover, Alexander ^d   McLaren, Gordon D ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

^c KAISER PERMANENTE   (United States)

^d St John's Hospital   (United States)

^e VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEMOCHROMATOSIS; HUMAN; INFORMED CONSENT; IRON DEFICIENCY; IRON OVERLOAD; MEDICAL EDUCATION; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING TEST; STANDARDIZATION;

EID: 0032403964     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_2-199812011-00007     Document Type: Article

References (48)

1. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta. 1996;245:139-200.
2. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2d ed. Boston: Little, Brown; 1991.
3. U.S. Preventive Service Task Force. Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force. 2d ed. Baltimore: Williams & Wilkins; 1996:231-46.
4. Cogswell ME, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G. Screening for hereditary hemochromatosis: where do we go from here? Ann Intern Med. 1998;129:971-9.
5. Wilson JM, Jungner YG. The Principles and Practice of Screening for Disease. Public Health Paper 34. Geneva: World Health Organization; 1968.
6. Borwein ST, Ghent GN, Flanagan PR, Chamberlain MJ, Valberg LS. Genetic and phenotypic expression of hemochromatosis in Canadians. Clin Invest Med. 1983;6:171-9.
7. Olsson KS, Ritter B, Rosen U, Heedman PA, Staugard F. Prevalence of iron overload in Central Sweden. Acta Med Scand. 1983;213:145-50.
8. Hallberg L, Bjorn-Rasmussen E, Jungner I. Prevalence of hereditary hemochromatosis in two Swedish urban areas. J Intern Med. 1989;225:249-55.
9. Elliott R, Lin BP, Dent OF, Tait A, Smith CI. Prevalence of hemochromatosis in a random sample of asymptomatic men. Aust N Z J Med. 1986;16: 491-5.
10. Tanner AR, Desai S, Lu W, Wright R. Screening for hemochromatosis in the UK: preliminary results. Gut. 1985;26:A1139-40.
11. Summary of a report on assessment of the iron nutritional status of the United States. Expert Scientific Working Group. Am J Clin Nutr. 1985;42:318-30.
12. Edwards CQ, Griffin LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355-62.
13. Meyer T, Baynes R, Bothwell T, Jenkins T, Joaste P, DuToit E, et al. Phenotypic expression of the HLA linked iron-loading gene in males over the age of 40 years: a population study using serial serum ferritin estimations. J Intern Med. 1990;227:397-406.
14. Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of hemochromatosis amongst asymptomatic Australians. Br J Haematol. 1990;74:525-30.
15. Lindmark B, Eriksson S. Prevalence of hemochromatosis [Letter]. N Engl J Med. 1988;319:1548-9.
16. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med. 1993;328:1616-20.
17. Neiderau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107-19.
18. Phatak PD, Sham RL, Raubertas RF, Dunnigan K, O'Leary MT, Braggins C, et al. Prevalence of hereditary hemochromatosis in 16 031 primary care patients. Ann Intern Med. 1998;129:954-61.
19. Bradley L, Haddow JE, Palomaki GE. Population based screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;3:178-84.
20. Bradley L, Haddow JE, Palomaki GE. Population screening for hemochromatosis: expectations based on a study of relatives of symptomatic probands. J Med Screen. 1996;3:171-7.
21. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med. 1998;129:925-31.
22. McDonnell SM, Witte D. Hereditary hemochromatosis. Preventing chronic effects of this underdiagnosed disorder. Postgrad Med. 1997;102:83-94.
23. Wurapa RK, Gordeuk VR, Brittenham GM, Khiyami A, Schechter GP, Edwards CQ. Primary iron overload in African-Americans. Am J Med. 1996; 101:9-18.
24. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am J Med. 1995;99:616-23.
25. Iron overload disorders among Hispanics - San Diego, California, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:991-3.
26. Looker AC, Johnson CL. Prevalence of elevated serum transferrin saturation in adults in the United States. Ann Intern Med. 1998;129:940-5.
27. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
28. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 1996; 22:187-94.
29. Barton JC, Shih WW, Sawada-Hirai R, Acton RT, Harmon L, Rivers C, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis. 1997;23:135-45.
30. Gunter E, McDonnell SM. Serum iron measures [Letter]. Clin Chem. 1998; 44:361-2.
31. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. 1997;336:823-7.
32. Clayton C, Hall P, Mackinnon M. Family screening for genetic haemochromatosis. What is the most effective method of contact? Med J Aust. 1993; 159:614-5.
33. Barton JC, Barton NH, Alford TJ. Diagnosis of hemochromatosis probands in a community hospital. Am J Med. 1997;103:498-503.
34. Crawford R. The Iron Elephant. Glyndon, MD: Vida Publishing; 1990.
35. Clayton EW, Steinberg KK, Khoury MJ, Thomson E, Andrews L, Kahn MJ, et al. Informed consent for genetic research on stored tissue samples. JAMA. 1995;274:1786-92.
36. Freeman V, Rotimi C, Cooper R. Hypertension prevalence, awareness, treatment, and control among African Americans in the 1990s: estimates from the Maywood Cardiovascular Survey. Am J Prev Med. 1996;12:177-85.
37. Grunbaum JA, Rodriguez BL, Labarthe DR. Parental response to identification of elevated blood pressure or cholesterol following school-based screening. J Adolesc Health. 1993;14:99-103.
38. Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med. 1994; 154:769-76.
39. Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem. 1994;40:1631-6.
40. Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Gastroenterology. 1995;109:177-88.
41. Balan V, Baldus W, Fairbanks V, Michels V, Burritt M, Klee G. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology. 1994;107:453-9.
42. Guidelines for the prevention and management of iron deficiency. MMWR Morb Mortal Wkly Rep. 1998;47:1-29.
43. Looker AC, Dallman PR, Carroll MO, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997;277:973-6.
44. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med. 1997;127:105-10.
45. Niederau C, Niederau CM, Lange S, Littauer A, Abdel-Jalil JN, Maurer M, et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med. 1998;128: 337-45.
46. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology. 1997;25:162-6.
47. McLaren CE, McLachlan GJ, Halliday JW, Webb SI, Leggett BA, Jazwinska EC, et al. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology. 1998;114:543-9.
48. Brittenham GM, Franks AL, Rickles FR. Research priorities in hereditary hemochromatosis. Ann Intern Med. 1998;129:993-6.